Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Patterns of immune development in urban preschoolers with recurrent wheeze and/or atopy.

Gern JE, Calatroni A, Jaffee KF, Lynn H, Dresen A, Cruikshank WW, Lederman HM, Sampson HA, Shreffler W, Bacharier LB, Gergen PJ, Gold DR, Kattan M, O'Connor GT, Sandel MT, Wood RA, Bloomberg GR.

J Allergy Clin Immunol. 2017 Sep;140(3):836-844.e7. doi: 10.1016/j.jaci.2016.10.052. Epub 2017 Jan 13.

2.

The influence of atopy and asthma on immune responses in inner-city adults.

Kakumanu S, Jaffee K, Visness CM, Dresen A, Burger M, Witter FR, O'Connor GT, Cruikshank WW, Shreffler WG, Bacharier LB, Gern JE.

Immun Inflamm Dis. 2016 Feb 26;4(1):80-90. doi: 10.1002/iid3.96. eCollection 2016 Mar.

3.

Relation between stress and cytokine responses in inner-city mothers.

Gruenberg DA, Wright RJ, Visness CM, Jaffee KF, Bloomberg GR, Cruikshank WW, Kattan M, Sandel MT, Wood RA, Gern JE.

Ann Allergy Asthma Immunol. 2015 Nov;115(5):439-445.e3. doi: 10.1016/j.anai.2015.07.021. Epub 2015 Sep 26.

4.

Role of IL-16 in CD4+ T cell-mediated regulation of relapsing multiple sclerosis.

Skundric DS, Cruikshank WW, Drulovic J.

J Neuroinflammation. 2015 Apr 22;12:78. doi: 10.1186/s12974-015-0292-x.

5.

Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.

Skundric DS, Cruikshank WW, Montgomery PC, Lisak RP, Tse HY.

Cytokine. 2015 Oct;75(2):234-48. doi: 10.1016/j.cyto.2015.01.005. Epub 2015 Feb 18.

PMID:
25703787
6.

Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma.

Tuzova M, Jean JC, Hughey RP, Brown LA, Cruikshank WW, Hiratake J, Joyce-Brady M.

Front Pharmacol. 2014 Jul 31;5:179. doi: 10.3389/fphar.2014.00179. eCollection 2014.

7.

Prenatal retinoid deficiency leads to airway hyperresponsiveness in adult mice.

Chen F, Marquez H, Kim YK, Qian J, Shao F, Fine A, Cruikshank WW, Quadro L, Cardoso WV.

J Clin Invest. 2014 Feb;124(2):801-11. doi: 10.1172/JCI70291. Epub 2014 Jan 9.

8.

An NT4/TrkB-dependent increase in innervation links early-life allergen exposure to persistent airway hyperreactivity.

Aven L, Paez-Cortez J, Achey R, Krishnan R, Ram-Mohan S, Cruikshank WW, Fine A, Ai X.

FASEB J. 2014 Feb;28(2):897-907. doi: 10.1096/fj.13-238212. Epub 2013 Nov 12.

9.

Mannose-capped lipoarabinomannan from Mycobacterium tuberculosis preferentially inhibits sphingosine-1-phosphate-induced migration of Th1 cells.

Richmond JM, Lee J, Green DS, Kornfeld H, Cruikshank WW.

J Immunol. 2012 Dec 15;189(12):5886-95. doi: 10.4049/jimmunol.1103092. Epub 2012 Nov 5.

10.

Comparison of the etiology of viral respiratory illnesses in inner-city and suburban infants.

Gern JE, Pappas T, Visness CM, Jaffee KF, Lemanske RF, Togias A, Bloomberg GR, Cruikshank WW, Lamm C, Tuzova M, Wood RA, Lee WM.

J Infect Dis. 2012 Nov;206(9):1342-9. doi: 10.1093/infdis/jis504. Epub 2012 Sep 25.

11.

Mannose-capped Lipoarabinomannan from Mycobacterium tuberculosis induces soluble tumor necrosis factor receptor production through tumor necrosis factor alpha-converting enzyme activation.

Richmond JM, Duffy ER, Lee J, Kaboli K, Kim YS, Remick DG, Kornfeld H, Cruikshank WW.

Infect Immun. 2012 Nov;80(11):3858-68. doi: 10.1128/IAI.00060-12. Epub 2012 Aug 27. Erratum in: Infect Immun. 2013 Feb;81(2):618. Kim, Yun Seong [added].

12.

Longitudinal relationship of early life immunomodulatory T cell phenotype and function to development of allergic sensitization in an urban cohort.

McLoughlin RM, Calatroni A, Visness CM, Wallace PK, Cruikshank WW, Tuzova M, Ly NP, Ruiz-Perez B, Kattan M, Bloomberg GR, Lederman H, Gern JE, Gold DR.

Clin Exp Allergy. 2012 Mar;42(3):392-404. doi: 10.1111/j.1365-2222.2011.03882.x. Epub 2011 Nov 9.

13.

Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.

Curiel-Lewandrowski C, Yamasaki H, Si CP, Jin X, Zhang Y, Richmond J, Tuzova M, Wilson K, Sullivan B, Jones D, Ryzhenko N, Little F, Kupper TS, Center DM, Cruikshank WW.

J Clin Invest. 2011 Dec;121(12):4838-49. doi: 10.1172/JCI41769. Epub 2011 Nov 14. Retraction in: J Clin Invest. 2014 Nov;124(11):5085.

14.

A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study.

Granada M, Wilk JB, Tuzova M, Strachan DP, Weidinger S, Albrecht E, Gieger C, Heinrich J, Himes BE, Hunninghake GM, Celedón JC, Weiss ST, Cruikshank WW, Farrer LA, Center DM, O'Connor GT.

J Allergy Clin Immunol. 2012 Mar;129(3):840-845.e21. doi: 10.1016/j.jaci.2011.09.029. Epub 2011 Nov 9.

15.

Diesel exhaust particulates exacerbate asthma-like inflammation by increasing CXC chemokines.

Kim J, Natarajan S, Vaickus LJ, Bouchard JC, Beal D, Cruikshank WW, Remick DG.

Am J Pathol. 2011 Dec;179(6):2730-9. doi: 10.1016/j.ajpath.2011.08.008. Epub 2011 Oct 1.

16.

Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism.

Meagher C, Beilke J, Arreaza G, Mi QS, Chen W, Salojin K, Horst N, Cruikshank WW, Delovitch TL.

Diabetes. 2010 Nov;59(11):2862-71. doi: 10.2337/db09-0131. Epub 2010 Aug 6.

17.

A homologous form of human interleukin 16 is implicated in microglia recruitment following nervous system injury in leech Hirudo medicinalis.

Croq F, Vizioli J, Tuzova M, Tahtouh M, Sautiere PE, Van Camp C, Salzet M, Cruikshank WW, Pestel J, Lefebvre C.

Glia. 2010 Nov 1;58(14):1649-62. doi: 10.1002/glia.21036.

PMID:
20578037
18.

Parental characteristics, somatic fetal growth, and season of birth influence innate and adaptive cord blood cytokine responses.

Gold DR, Bloomberg GR, Cruikshank WW, Visness CM, Schwarz J, Kattan M, O'Connor GT, Wood RA, Burger MS, Wright RJ, Witter F, Lee-Parritz A, Sperling R, Sadovsky Y, Togias A, Gern JE.

J Allergy Clin Immunol. 2009 Nov;124(5):1078-87. doi: 10.1016/j.jaci.2009.08.021.

19.

Dermal nitrite application enhances global nitric oxide availability: new therapeutic potential for immunomodulation?

Garcia-Saura MF, Fernandez BO, McAllister BP, Whitlock DR, Cruikshank WW, Feelisch M.

J Invest Dermatol. 2010 Feb;130(2):608-11. doi: 10.1038/jid.2009.303. Epub 2009 Oct 8. No abstract available.

20.

Characterization of regulatory T cells in urban newborns.

Ly NP, Ruiz-Perez B, McLoughlin RM, Visness CM, Wallace PK, Cruikshank WW, Tzianabos AO, O'Connor GT, Gold DR, Gern JE.

Clin Mol Allergy. 2009 Jul 8;7:8. doi: 10.1186/1476-7961-7-8.

21.

Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.

Radstake TR, van Bon L, Broen J, Wenink M, Santegoets K, Deng Y, Hussaini A, Simms R, Cruikshank WW, Lafyatis R.

PLoS One. 2009 Jun 22;4(6):e5981. doi: 10.1371/journal.pone.0005981.

22.

Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy.

Green DS, Center DM, Cruikshank WW.

J Virol. 2009 Jun;83(11):5765-72. doi: 10.1128/JVI.00130-09. Epub 2009 Mar 18.

23.

Transforming growth factor beta1 and laminin-111 cooperate in the induction of interleukin-16 expression in synovial fibroblasts from patients with rheumatoid arthritis.

Warstat K, Hoberg M, Rudert M, Tsui S, Pap T, Angres B, Essl M, Smith TJ, Cruikshank WW, Klein G, Gay S, Aicher WK.

Ann Rheum Dis. 2010 Jan;69(1):270-5. doi: 10.1136/ard.2008.091116.

24.

Immunosuppressive effect on T cell activation by interleukin-16- and interleukin-10-cDNA-double-transfected human squamous cell line.

Matsumoto Y, Fujita T, Hirai I, Sahara H, Torigoe T, Ezoe K, Saito T, Cruikshank WW, Yotsuyanagi T, Sato N.

Burns. 2009 May;35(3):383-9. doi: 10.1016/j.burns.2008.06.017. Epub 2008 Oct 23.

PMID:
18950955
25.

Functional Th1 cells are required for surgical adhesion formation in a murine model.

Tzianabos AO, Holsti MA, Zheng XX, Stucchi AF, Kuchroo VK, Strom TB, Glimcher LH, Cruikshank WW.

J Immunol. 2008 May 15;180(10):6970-6976.

26.

Measurement of interleukin 16.

Center DM, Cruikshank WW, Parada NA, Ryan T, Theodore AC, Viglianti G, Lim KG, Weller PF.

Curr Protoc Immunol. 2001 May;Chapter 6:Unit 6.23. doi: 10.1002/0471142735.im0623s22.

PMID:
18432814
27.

Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP.

Zhang Y, Tuzova M, Xiao ZX, Cruikshank WW, Center DM.

J Immunol. 2008 Jan 1;180(1):402-8.

28.

Lung lining fluid glutathione attenuates IL-13-induced asthma.

Lowry MH, McAllister BP, Jean JC, Brown LA, Hughey RP, Cruikshank WW, Amar S, Lucey EC, Braun K, Johnson P, Wight TN, Joyce-Brady M.

Am J Respir Cell Mol Biol. 2008 May;38(5):509-16. Epub 2007 Dec 6.

29.

Decreased renal ischemia-reperfusion injury by IL-16 inactivation.

Wang S, Diao H, Guan Q, Cruikshank WW, Delovitch TL, Jevnikar AM, Du C.

Kidney Int. 2008 Feb;73(3):318-26. Epub 2007 Nov 14.

30.

Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model.

Morgan RK, McAllister B, Cross L, Green DS, Kornfeld H, Center DM, Cruikshank WW.

J Immunol. 2007 Jun 15;178(12):8081-9.

31.

Standardization and performance evaluation of mononuclear cell cytokine secretion assays in a multicenter study.

Shreffler WG, Visness CM, Burger M, Cruikshank WW, Lederman HM, de la Morena M, Grindle K, Calatroni A, Sampson HA, Gern JE.

BMC Immunol. 2006 Dec 12;7:29.

32.
33.

Chemokine receptor CXCR3 desensitization by IL-16/CD4 signaling is dependent on CCR5 and intact membrane cholesterol.

Rahangdale S, Morgan R, Heijens C, Ryan TC, Yamasaki H, Bentley E, Sullivan E, Center DM, Cruikshank WW.

J Immunol. 2006 Feb 15;176(4):2337-45.

34.
35.

Regulation of nuclear Prointerleukin-16 and p27(Kip1) in primary human T lymphocytes.

Wilson KC, Cattel DJ, Wan Z, Rahangdale S, Ren F, Kornfeld H, Sullivan BA, Cruikshank WW, Center DM.

Cell Immunol. 2005 Sep;237(1):17-27. Epub 2005 Nov 9.

PMID:
16289056
36.

Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE).

Skundric DS, Zhou W, Cruikshank WW, Dai R.

J Autoimmun. 2005 Nov;25(3):206-14. Epub 2005 Nov 2.

PMID:
16271292
37.

Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.

Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z.

J Neurosci Res. 2005 Mar 1;79(5):680-93.

PMID:
15682385
39.

The effect of interleukin-16 and its precursor on T lymphocyte activation and growth.

Wilson KC, Center DM, Cruikshank WW.

Growth Factors. 2004 Jun;22(2):97-104. Review.

PMID:
15253385
40.

Interleukin-16 and peptide derivatives as immunomodulatory therapy in allergic lung disease.

Little FF, Cruikshank WW.

Expert Opin Biol Ther. 2004 Jun;4(6):837-46. Review.

PMID:
15174966
41.
42.

Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5.

Lynch EA, Heijens CA, Horst NF, Center DM, Cruikshank WW.

J Immunol. 2003 Nov 15;171(10):4965-8.

43.

Immunomodulatory cytokines in asthmatic inflammation.

Lynch EL, Little FF, Wilson KC, Center DM, Cruikshank WW.

Cytokine Growth Factor Rev. 2003 Dec;14(6):489-502. Review.

PMID:
14563351
44.
45.
47.

Immunomodulatory effect of interleukin-16 on allergic airway inflammation.

Little FF, de Bie J, van Oosterhout A, Kornfeld H, Center DM, Cruikshank WW.

Chest. 2003 Mar;123(3 Suppl):431S-2S. Review. No abstract available.

PMID:
12629022
48.

Binding of HTLV-1 tax oncoprotein to the precursor of interleukin-16, a T cell PDZ domain-containing protein.

Wilson KC, Center DM, Cruikshank WW, Zhang Y.

Virology. 2003 Feb 1;306(1):60-7.

49.

Tumor necrosis factor-alpha-induced synthesis of interleukin-16 in airway epithelial cells: priming for serotonin stimulation.

Little FF, Lynch E, Fine G, Center DM, Cruikshank WW.

Am J Respir Cell Mol Biol. 2003 Mar;28(3):354-62.

PMID:
12594062
50.

Exogenous interleukin-16 inhibits antigen-induced airway hyper-reactivity, eosinophilia and Th2-type cytokine production in mice.

De Bie JJ, Jonker EH, Henricks PA, Hoevenaars J, Little FF, Cruikshank WW, Nijkamp FP, Van Oosterhout AJ.

Clin Exp Allergy. 2002 Nov;32(11):1651-8.

PMID:
12569988

Supplemental Content

Loading ...
Support Center